{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:23:00Z","timestamp":1792732980333,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form of AML, acute promyelocytic leukemia (APL) has become more than 90% curable with differentiation therapy, consisting of all-<jats:italic>trans<\/jats:italic>-retinoic acid (ATRA) and arsenic trioxide (ATO). Application of differentiation therapy to other AML subtypes would be a major treatment advance. Recent studies have indicated that autophagy plays a key role in the differentiation of ATRA-responsive APL cells. In this study, we have investigated whether differentiation could be enhanced in ATRA resistant cells by promoting autophagy induction with valproic acid (VPA). ATRA sensitive (NB4) and resistant leukemia cells (NB4R and THP-1) were co-treated with ATRA and valproic acid, followed by assessment of autophagy and differentiation. The combination of VPA and ATRA induced autophagic flux and promoted differentiation in ATRA-sensitive and -resistant cell lines. shRNA knockdown of ATG7 and TFEB autophagy regulators impaired both autophagy and differentiation, demonstrating the importance of autophagy in the combination treatment. These data suggest that ATRA combined with valproic acid can promote differentiation in myeloid leukemia cells by mechanism involving autophagy.<\/jats:p>","DOI":"10.3389\/fonc.2022.848517","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T05:17:08Z","timestamp":1645679828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism"],"prefix":"10.3389","volume":"12","author":[{"given":"Dalyia N.","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey R.","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian B.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Orfali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary R.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel P.","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine J.","family":"Gudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and Management of AML in Adults: 2017 ELN Recommendations From an International Expert Panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1182\/asheducation-2014.1.14","article-title":"Treating Acute Myeloid Leukemia in Older Adults","volume":"2014","author":"Wang","year":"2014","journal-title":"Hematol (U States)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1011","article-title":"Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges","volume":"10","author":"Short","year":"2020","journal-title":"Cancer Discov"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40487-018-0091-5","article-title":"Acute Promyelocytic Leukemia: A History Over 60 Years\u2014From the Most Malignant to the Most Curable Form of Acute Leukemia","volume":"7","author":"Thomas","year":"2019","journal-title":"Oncol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/35895","article-title":"Role of the Histone Deacetylase Complex in Acute Promyelocytic Leukaemia","volume":"391","author":"Lin","year":"1998","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1065173","article-title":"Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor","volume":"295","author":"Di Croce","year":"2002","journal-title":"Sci (80- )"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/35901","article-title":"Fusion Proteins of the Retinoic Acid Receptor-\u03b1 Recruit Histone Deacetylase in Promyelocytic Leukaemia","volume":"391","author":"Grignani","year":"1998","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.201112044","article-title":"Acute Promyelocytic Leukemia, Arsenic, and PML Bodies","volume":"198","author":"de Th\u00e9","year":"2012","journal-title":"J Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208286","article-title":"Retinoic Acid Targets DNA-Methyltransferases and Histone Deacetylases During APL Blast Differentiation In Vitro and In Vivo","volume":"24","author":"Fazi","year":"2005","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2013.08.002","article-title":"Retinoids Induce Stem Cell Differentiation via Epigenetic Changes","volume":"24","author":"Gudas","year":"2013","journal-title":"Semin Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2014.03.018","article-title":"Retinoid Receptor Signaling and Autophagy in Acute Promyelocytic Leukemia","volume":"324","author":"Orfali","year":"2014","journal-title":"Exp Cell Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10541","article-title":"Arsenic But Not All-Trans Retinoic Acid Overcomes the Aberrant Stem Cell Capacity of PML\/Rar\u03b1-Positive Leukemic Stem Cells","volume":"92","author":"Zheng","year":"2007","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2040620718816698","article-title":"Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options","volume":"10","author":"Bewersdorf","year":"2019","journal-title":"Ther Adv Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11111794","article-title":"HDAC Inhibitors in Acute Myeloid Leukemia","volume":"11","author":"Jos\u00e9-En\u00e9riz","year":"2019","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2018.2215","article-title":"Biological Roles of Alternative Autophagy","volume":"41","author":"Shimizu","year":"2018","journal-title":"Mol Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1203489","article-title":"Alternative Autophagy, Brefeldin A and Viral Trafficking Pathways","volume":"12","author":"Grose","year":"2016","journal-title":"Autophagy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.023","article-title":"Molecular Mechanisms and Physiological Roles of Atg5\/Atg7-Independent Alternative Autophagy","volume":"93","author":"Arakawa","year":"2017","journal-title":"Proc Japan Acad Ser B: Phys Biol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13962","article-title":"Mechanistic Roles of Autophagy in Hematopoietic Differentiation","volume":"284","author":"Riffelmacher","year":"2017","journal-title":"FEBS J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101145","article-title":"The Autophagy Protein Atg7 is Essential for Hematopoietic Stem Cell Maintenance","volume":"208","author":"Mortensen","year":"2011","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddiscovery.2015.8","article-title":"Autophagy Limits Proliferation and Glycolytic Metabolism in Acute Myeloid Leukemia","volume":"1","author":"Watson","year":"2015","journal-title":"Cell Death Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbamcr.2014.09.023","article-title":"Autophagy in Acute Leukemias: A Double-Edged Sword With Important Therapeutic Implications","volume":"1853","author":"Evangelisti","year":"2015","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1482795","article-title":"Low Autophagy (ATG) Gene Expression Is Associated With an Immature AML Blast Cell Phenotype and can be Restored During AML Differentiation Therapy","volume":"2018","author":"Jin","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.exphem.2015.04.012","article-title":"Induction of Autophagy Is a Key Component of All-Trans-Retinoic Acid-Induced Differentiation in Leukemia Cells and a Potential Target for Pharmacologic Modulation","volume":"43","author":"Orfali","year":"2015","journal-title":"Exp Hematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13367","article-title":"All-Trans Retinoic Acid (ATRA)-Induced TFEB Expression Is Required for Myeloid Differentiation in Acute Promyelocytic Leukemia (APL)","volume":"104","author":"Orfali","year":"2020","journal-title":"Eur J Haematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.9.9.11436","article-title":"Phase I Trial of ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies","volume":"9","author":"David","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22891","article-title":"Valproic Acid for the Treatment of Myeloid Malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential Valproic Acid\/All-Trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1868-7083-5-12","article-title":"Histone Deacetylase Inhibition in the Treatment of Acute Myeloid Leukemia: The Effects of Valproic Acid on Leukemic Cells, and the Clinical and Experimental Evidence for Combining Valproic Acid With Other Antileukemic Agents","volume":"5","author":"Fredly","year":"2013","journal-title":"Clin Epigenet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500629","article-title":"Targeting Autophagy Potentiates the Apoptotic Effect of Histone Deacetylase Inhibitors in T (8,21) AML Cells","volume":"122","author":"Torgersen","year":"2013","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1082024","article-title":"Induction of Autophagy by Valproic Acid Enhanced Lymphoma Cell Chemosensitivity Through HDAC-Independent and IP3-Mediated PRKAA Activation","volume":"11","author":"Ji","year":"2015","journal-title":"Autophagy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4880","article-title":"Valproic Acid Induces Autophagy by Suppressing the Akt\/mTOR Pathway in Human Prostate Cancer Cells","volume":"12","author":"Xia","year":"2016","journal-title":"Oncol Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2020.110167","article-title":"Valproic Acid Increased Autophagic Flux in Human Multiple Myeloma Cells In Vitro","volume":"127","author":"Wang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A New Mathematical Model for Relative Quantification in Real-Time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic Acid Defines a Novel Class of HDAC Inhibitors Inducing Differentiation of Transformed Cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid, and All-Trans Retinoic Acid in Acute Myeloid Leukemia and Myelodysplastic Syndrome","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and Mechanisms of Non-Histone Protein Acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.01.033","article-title":"Acetylome and Phosphoproteome Modifications in Imatinib Resistant Chronic Myeloid Leukaemia Cells Treated With Valproic Acid","volume":"35","author":"Buchi","year":"2011","journal-title":"Leuk Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3841","article-title":"The Growing Landscape of Lysine Acetylation Links Metabolism and Cell Signalling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells8121656","article-title":"Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes","volume":"8","author":"Peixoto","year":"2019","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.12.027","article-title":"Epigenetic Control of Autophagy: Nuclear Events Gain More Attention","volume":"65","author":"Baek","year":"2017","journal-title":"Mol Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.02.001","article-title":"Regulation of Autophagy and Mitophagy by Nutrient Availability and Acetylation","volume":"1841","author":"Webster","year":"2014","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14846","article-title":"A Semisynthetic Atg3 Reveals That Acetylation Promotes Atg3 Membrane Binding and Atg8 Lipidation","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1447290","article-title":"Importance of TFEB Acetylation in Control of its Transcriptional Activity and Lysosomal Function in Response to Histone Deacetylase Inhibitors","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-11-89","article-title":"Acetylated Microtubules Are Required for Fusion of Autophagosomes With Lysosomes","volume":"11","author":"Xie","year":"2010","journal-title":"BMC Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.650028","article-title":"Hierarchal Autophagic Divergence of Hematopoietic System","volume":"290","author":"Cao","year":"2015","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients With Acute Myelogenous Leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1719098","article-title":"Venetoclax in Acute Myeloid Leukemia \u2013 Current and Future Directions","volume":"61","author":"Lachowiez","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B49","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.beha.2021.101251","article-title":"Mechanisms for Resistance in AML Insights Into Molecular Pathways Mediating Resistance to Venetoclax","volume":"34","author":"Konopleva","year":"2021","journal-title":"Best Pract Res: Clin Haematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601689","article-title":"Functional and Physical Interaction Between Bcl-XL and a BH3-Like Domain in Beclin-1","volume":"26","author":"Maiuri","year":"2007","journal-title":"EMBO J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4161\/auto.4237","article-title":"BH3-Only Proteins and BH3 Mimetics Induce Autophagy by Competitively Disrupting the Interaction Between Beclin 1 and Bcl-2\/Bcl-Xl","volume":"3","author":"Maiuri","year":"2007","journal-title":"Autophagy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2017.03.006","article-title":"Multifaceted Anticancer Activity of BH3 Mimetics: Current Evidence and Future Prospects","volume":"136","author":"Opydo-Chanek","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12132","article-title":"Acquired Resistance to Venetoclax (ABT-199) in T (14,18) Positive Lymphoma Cells","volume":"7","author":"Bodo","year":"2016","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S281519","article-title":"BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells","volume":"13","author":"Alhoshani","year":"2020","journal-title":"Onco Targets Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.848517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T05:17:12Z","timestamp":1645679832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.848517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":54,"alternative-id":["10.3389\/fonc.2022.848517"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.848517","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"848517"}}